BioAdaptives, Inc. (BDPT)
- Previous Close
0.0003 - Open
0.0003 - Bid 0.0002 x --
- Ask 0.0003 x --
- Day's Range
0.0002 - 0.0003 - 52 Week Range
0.0002 - 0.0014 - Volume
23,997,019 - Avg. Volume
20,947,071 - Market Cap (intraday)
369,519 - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, improves wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow. It also provides SleepEZ for use as an aid to relaxation; Lung Flute, a medical device, and PrimiLungs, a formulation of nutraceuticals promoting overall health and wellness through support of pulmonary immune systems in its Lung Armor packaging; and animal products, including Equine All-in-One and Equine All-In-One Plus formulation for trainers, horse owners, and boarding stables, as well as a Canine All-in-One that is marketed directly to consumers. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
www.shopbioadaptives.com3
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BDPT
View MorePerformance Overview: BDPT
Trailing total returns as of 11/6/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BDPT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BDPT
View MoreValuation Measures
Market Cap
369.52k
Enterprise Value
719.76k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.89
Price/Book (mrq)
--
Enterprise Value/Revenue
20.26
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-611.40%
Return on Equity (ttm)
--
Revenue (ttm)
35.52k
Net Income Avi to Common (ttm)
-771.09k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
235
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
90.58k